Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22.2M
-
Number of holders
-
58
-
Total 13F shares, excl. options
-
64M
-
Shares change
-
+39.3M
-
Total reported value, excl. options
-
$48.1M
-
Value change
-
+$29.2M
-
Put/Call ratio
-
0.05
-
Number of buys
-
41
-
Number of sells
-
-7
-
Price
-
$0.75
Significant Holders of Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) as of Q4 2023
64 filings reported holding ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share as of Q4 2023.
Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) has 58 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 64M shares
.
Largest 10 shareholders include COMMODORE CAPITAL LP (10M shares), FMR LLC (6.12M shares), MORGAN STANLEY (5.15M shares), VR Adviser, LLC (5.15M shares), Versant Venture Management, LLC (5.07M shares), BML Capital Management, LLC (4.55M shares), GOLDMAN SACHS GROUP INC (4.55M shares), BANK OF AMERICA CORP /DE/ (4.3M shares), VANGUARD GROUP INC (4.19M shares), and AIGH Capital Management LLC (3.17M shares).
This table shows the top 58 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.